Unsealed FCA Suit Accuses Pfizer Of Off-Label Marketing

By Erin Coe · November 29, 2011, 10:40 PM EST

A federal court on Tuesday unsealed two ex-Pfizer Inc. employees' qui tam suit alleging the drugmaker marketed anti-fungal medication Vfend for off-label use that put patients at risk and caused the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

VEZEAU, ET AL v. PFIZER, INC.

Case Number

2:05-cv-06795

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

December 29, 2005